Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate CancersAna M. Aparicio, Christopher J. Logothetis, Li Shen et al.|Clinical Cancer Research|2015Cited by 297
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 SignalingStyliani Karanika, Timothy C. Thompson, Ganiraju C. Manyam et al.|Cell Reports|2017Cited by 107
Targeting Poly(ADP-Ribose) Polymerase and the c-Myb–Regulated DNA Damage Response Pathway in Castration-Resistant Prostate CancerLikun Li, Timothy C. Thompson, Wenjun Chang et al.|Science Signaling|2014Cited by 87
A comprehensive molecular characterization of aggressive variant prostate cancer (PC).Ana M. Aparicio, Sankar N. Maity, Li Shen et al.|Journal of Clinical Oncology|2015Cited by 2
Abstract 4674: Targeting cancer stem-cells in aggressive variant prostate cancersRama Soundararajan, Sendurai A. Mani, Paul Allegakoen et al.|Tumor Biology|2019Cited by 1